Navigation Links
Bionovo Adds Dr. Debu Tripathy to Their Medical Advisory Board
Date:10/14/2009

EMERYVILLE, Calif., Oct. 14 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI) announced today the appointment of Dr. Debu Tripathy, Professor of Medicine and Co-Director of the Women's Cancer Program at the University Southern California, to the company's Medical Advisory Board. Dr. Tripathy is a world renowned leader and researcher in the area of breast cancer.

"We are honored to have one of the world's foremost authorities in the area of breast cancer join our Medical Advisory Board. Dr. Tripathy's depth of knowledge in cancer biology and vast expertise in the design and conduct of multinational clinical trials for all stages of breast cancer will be an extraordinary asset to the company while we advance Bezielle and Menerba through clinical development," said Dr. Mary Tagliaferri, Bionovo's President and Chief Medical Officer.

Dr. Tripathy states, "After 13 years of close academic collaboration with Drs. Cohen and Tagliaferri, the co-founders of Bionovo, I am very excited to join their prestigious Medical Advisory Board to further advance two of the most promising drugs for women's health and breast cancer, namely, Menerba and Bezielle. As a clinician I am aware of the fear, risk and consequences of encountering breast cancer. Since the risk of developing breast cancer associated with hormone therapy use for menopausal symptoms is the number one reason women do not initiate hormone therapy, Menerba, with its indicated improved safety, has great potential to be a blockbuster drug in the near future. To date, Menerba, has proven to be efficacious in clinical testing and pre-clinical models indicate Menerba will not cause either breast or uterine cancer. "

Dr. Tripathy continues, "In addition, Bionovo's Bezielle, for the treatment of metastatic breast cancer, has enormous potential as a novel, oral agent wit
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bionovo Announces Pricing of Securities Offering
2. Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency
3. Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
4. Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer
5. Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference
6. Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied
7. Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009
8. Bionovo to Present at the Cambria Capital Investor Meeting
9. Bionovo to Present at Wall Street Analyst Forums 20th Annual Institutional Investor Conference
10. Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009
11. Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovos Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... IN (PRWEB) October 20, 2014 ... Start, a secure cloud solution that enables healthcare ... of the ultimate healthcare-specific customer relationship management (“CRM”) ... meet the unique needs of the healthcare industry, ... experience for providers and patients by combining healthcare ...
(Date:10/20/2014)... October 20, 2014 JZ Fitness, an ... coaching, corporate wellness programming, authorship, international lecturing and community ... to announce the release of the JZ Fitness nutrition ... years of coaching thousands of individuals on nutrition, Jenn ... that does not require calorie counting or cumbersome food ...
(Date:10/20/2014)... Principle Business Enterprises, a family owned ... top-of-the-line absorbent products. The company has recently made ... brand, Tranquility® Premium Protection absorbent products. The company ... its packaging a new look, and is currently working ... the public. , The new website, developed with Thread ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Voicheck as Assistant Director of their CentralSource ... in managing the innovative turnkey drug sourcing, distribution, ... Matthew brings over 12 years of industry experience, ... Myoderm at the peak of their international success ...
(Date:10/20/2014)... Portland, Oregon (PRWEB) October 20, 2014 Succeed ... 16% of local companies who participated in the Every ... Walk! is a public awareness project that encourages workers to ... the Summer Step 10,000 Program, which concluded at the end ... wide variety of cities and metro areas. Participating companies ...
Breaking Medicine News(10 mins):Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2
... by menopausal women causes a type of ovarian cancer to ... researchers at the University of Colorado Cancer Center. Menopausal ... the cancer metastasizing to the lymph nodes, according to the ... of Cancer Research . The study was released online ...
... 20 (HealthDay News) -- A combination of animal and human ... that could ultimately help in the treatment of major depression, ... of a brain protein known as p11. The study authors ... feelings of reward, pleasure and satisfaction with positive life experiences. ...
... black rice a little-known variety of the grain that ... may help soothe the inflammation involved in allergies, asthma, ... Journal of Agricultural and Food Chemistry . Mendel Friedman ... potential health benefits of eating black rice bran. Bran is ...
... -- Scientists have identified common genetic variations that may explain ... E is an antioxidant found in a number of oils, ... peppers, tomatoes and pumpkins. Previous research has found that vitamin ... vitamin in a person,s body. It,s been suspected that this ...
... , WEDNESDAY, Oct. 20 (HealthDay News) -- People ... for potentially serious eye damage, says a small new study ... which is located near the center of the retina at ... detailed central vision and the processing of light. In ...
... , TUESDAY, Oct. 19 (HealthDay News) -- Men ... premature death from heart disease and all causes, a finding ... factor for cardiovascular disease, according to new research. The ... followed-up for about seven years. At the start of the ...
Cached Medicine News:Health News:Estrogen replacement therapy speeds ovarian cancer growth, new study reports 2Health News:Animal Study Explores Potential Gene Therapy for Depression 2Health News:Animal Study Explores Potential Gene Therapy for Depression 3Health News:People With Anorexia May Risk Serious Eye Damage 2Health News:Low Testosterone May Raise Risk of Early Death: Study 2
(Date:10/20/2014)... de octubre de 2014  PneumRx, Inc. ( ... la pulmonología intervencional, anunció hoy la conclusión de ... meses antes de lo programado. El Estudio Clínico RENEW ... de investigación (IDE) aprobada por la FDA (Administración ... espiral de reducción de volumen pulmonar PneumRx RePneu, ...
(Date:10/20/2014)... Oct. 20, 2014 Valeritas, Inc., a leader ... patients with Type 2 diabetes, announced today that it ... Award. The award was presented October 16 th ... Columbus, Ohio . The Cardinal ... a variety of metrics specifically targeted at the importance ...
(Date:10/20/2014)... 2014 Lpath, Inc. (NASDAQ: ... therapeutics, received official notification from the European Patent Office ... patent supporting its iSONEP™ and ASONEP™ programs. ... No. 2087002, claims compositions of matter related to ... compounds, iSONEP and ASONEP. Sonepcizumab is an antibody ...
Breaking Medicine Technology:PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 2Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 3Lpath Granted Key European Patent Related to iSONEP and ASONEP Programs 4
... Mich., Jan. 9, 2012  Diplomat Specialty Pharmacy, the nation,s ... today it has received limited distribution rights from ... On November 18, 2011, EYLEA ... Drug Administration and is indicated for the treatment ...
... Calif., Jan. 9, 2012 Uptake Medical ® ... C funding round. The round was led by Singapore-based ... Ventures, GBS Venture Partners, WRF Capital, Arboretum Ventures and ... managing partner, will join the Uptake Medical board of ...
Cached Medicine Technology:Diplomat Specialty Pharmacy to Provide Specialty Pharmacy Services for EYLEA™ (aflibercept) Injection 2Uptake Medical Announces Successful Completion of Series C Financing 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: